A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren’s syndrome - Concepedia

Concepedia

Publication | Open Access

A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren’s syndrome

DOI Full Paper Access

42

Citations

15

References

2020

Year

Maria Juárez, Nieves Díaz, Geoffrey I. Johnston, Saba Nayar, Andrew Payne, Eric Helmer, Dionne Cain, Paulette Williams, Valérie Devauchelle‐Pensec, Benjamin A. Fisher,

Abstract

https://clinicaltrials.gov, NCT02610543.

References

	Year	Citations

Page 1